Skip to main content
Bart Clarke, MD, Endocrinology, Rochester, MN

BartLClarkeMD

Endocrinology Rochester, MN

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Parathyroid

Professor of Medicine

Dr. Clarke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Clarke's full profile

Already have an account?

  • Office

    200 1st St SW
    Rochester, MN 55905
    Phone+1 507-284-2511

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1992
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1986 - 1989
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1986

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1987 - 2025
  • IA State Medical License
    IA State Medical License 1998 - 2006
  • IL State Medical License
    IL State Medical License 1994 - 1999
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians, 1996
  • Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 Inhibitor 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • PTH Replacement Therapy in Hypoparathyroidism: When and How to Proceed 
    ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
  • Opening Comments: 2018 Parathyroid Summit: A Focus on Hypoparathyroidism 
    ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018

Press Mentions

  • Sustained Benefits with TransCon PTH in Hypoparathyroidism
    Sustained Benefits with TransCon PTH in HypoparathyroidismNovember 18th, 2024
  • Parathyroid Hormone Therapy Normalizes Calcium for Most with Hypoparathyroidism
    Parathyroid Hormone Therapy Normalizes Calcium for Most with HypoparathyroidismOctober 15th, 2024
  • Providers and Patients Can Help Minimize Risks of Steroid-Induced Osteoporosis, ACR Says
    Providers and Patients Can Help Minimize Risks of Steroid-Induced Osteoporosis, ACR SaysSeptember 22nd, 2022
  • Join now to see all

Committees

  • Co-Chair, ASBMR Development Committee 2014 - Present
  • Member, ASBMR Council 2013 - Present
  • Member, The Endocrine Society Development Committee 2009 - Present
  • Member, FDA Advisory Committee on Reproductive Health Drugs 2010 - 2013

Professional Memberships

Other Languages

  • French